A. Borg

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

L. Holmberg, P. Hall, Y. Pawitan, 2005, Breast Cancer Research.

Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen.

J. Bergh, H. Nordgren, A. Borg, 2006, European journal of cancer.

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

J. Bergh, A. Borg, N. Tobin, 2013, BMC Cancer.

Impairment of sodium pump and Na+/H+ antiport in erythrocytes isolated from cancer patients.

A. Borg, P. Gallice, R. Favre, 1996, Cancer research.

Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers.

T. Lindahl, J. Bergh, A. Borg, 2004, European journal of cancer.

Proteinase K added to the extraction procedure markedly increases RNA yield from primary breast tumors for use in microarray studies.

J. Bergh, J. Bjöhle, A. Borg, 2004, Clinical chemistry.

Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome.

J. Isola, J. Smeds, H. Nordgren, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison between radiation-induced cell cycle delay in lymphocytes and radiotherapy response in head and neck cancer.

F. Granath, A. Borg, R. Lewensohn, 1998, British Journal of Cancer.

Abstract P6-12-05: Ways To Understand Mechanism of Action for Targeted Drugs? Gene Expression Analyses from Paired Biopsies in Patients with Advanced Breast Cancer in a Substudy from the Randomized Study Docetaxel +/− Sunitinib A6181064

J. Bergh, J. Smeds, K. Kern, 2010 .

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

J. Bergh, A. Borg, N. Tobin, 2013, BMC Cancer.